The main thing would be how you market it since one of the provisions is that you can’t use that trademarked name, and I imagine that would apply to marketing it, not just the product name itself.

Comments URL: https://news.ycombinator.com/item?id=49853698

Points: 4

# Comments: 0

Neither appears to be on track to long-term profitability specifically once you take into account depreciation on CAPEX.

On top of this the “productivity gains” from AI across the board seem to be a very mixed bag. The pitch from these companies has been huge gains in productivity and automation and although there is anecdotal evidence some people are able to do that, the broader studies seem to show marginal gains in most cases.

But as you say the always-on ECG of a strap like Polar H10 always going to provide a superior result.

I do wear it for workouts, but once it's closer to end of life will replace it with something dedicated for workouts like a Garmin that holds a charge for 14+ days.

Comments URL: https://news.ycombinator.com/item?id=49253726

Points: 3

# Comments: 0

You know what does bother me?

The scintillating scotoma as well as retinal migraine symptoms, the former starting in middle school and latter in my 20s. Fortunately neither is frequent now but damn I used to break into a cold sweat with either and to this day am a bit reluctant to drive because of both.

They point out some limitations in their study:

> This study has several limitations. First, we collected the claims data based on ICD-19 codes, which led to potential errors regarding mismatching or misclassification could have occurred. Second, previous studies have suggested the impact of poverty rates on mental disorders but there are differences in the baseline characteristics between the two groups in this study [45, 46].

...

> Third, we measured psychiatric AEs up to three months following COVID-19 vaccination. This study did not contain the long-term follow-up COVID-19 vaccine-associated AEs. Last, despite being a population-based study targeting the population in Seoul, South Korea, it cannot be generalized to the entire population, globally since psychiatric disorders could be related to ethnic and genetic backgrounds.

And summarize their conclusion as such:

> In conclusion, this population-based cohort study revealed that COVID-19 vaccination differentially affects occurrences of psychiatric disorders. It increased the risks of depression, anxiety, dissociative, stress-related, and somatoform disorders, and sleep disorders while reducing the incidence and risk of schizophrenia and bipolar disorder. Our findings suggested that the relationship between COVID-19 vaccination and mental illness may be underestimated along with the complexity of its impact on mental health.